Chen Kai, Gao Yanyan, Xia Ninuo, Liu Yusheng, Wang Huiru, Ma Hui, Zheng Shengxia, Fang Fang
Reproductive Medicine Center and Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Anhui Tianlun Infertility Specialist Hospital, Hefei, China.
Stem Cell Res Ther. 2024 Dec 23;15(1):499. doi: 10.1186/s13287-024-04100-9.
Intrauterine adhesion (IUA), resulting from uterine trauma, is one of the major causes of female infertility. Previous studies have demonstrated that endometrial mesenchymal stem cells (eMSC) have therapeutic effects on IUA through cellular secretions. It is particularly true for most of the pre-clinical experiments performed on multiple animal models, as human-derived eMSC cannot maintain long-term engraftment in animals. Whether tissue-specific MSCs from allogeneic origin can engraft and exert long-term therapeutic efficacy has yet to be thoroughly explored.
We established a rat IUA model to study the long-term engraftment and therapeutic effects of eMSC derived from humans and rats. Human and rat eMSC were isolated and verified by the expression of cell surface markers and the ability to differentiate into osteoblasts, adipocytes, and chondrocytes. The cells were then labeled by green fluorescence proteins (GFP) and transplanted to the rat uterus ex vivo and in vivo. The engraftment was investigated by the expression of GFP at different days after transplantation. Assessed the therapeutic effects by examining the endometrial thickness, the number of glands, and the pregnancy outcome. Significantly, we conducted a thorough assessment of the local cellular immune response following both xenograft and allograft transplantation.
H-eMSC were eliminated by rats' immune systems within three days after transplantation. In constrast, R-eMSC successfully engrafted and persisted in rat tissue for over ten days. Notably, R-eMSC significantly improved the pregnancy rate by enhancing endometrial thickness and increasing the number of glands, while also reducing fibrosis in rat IUA models. Additionally, the immune response to R-eMSC was generally less aggressive compared to that of xenogeneic MSCs.
Tissue-specific MSCs from the allogeneic origin can integrate into the repaired tissue and exert long-term therapeutic efficacy in the model of IUA. This study indicates that in addition to secreting therapeutic factors short-time, tissue-specific MSCs may engraft and participate in long-time tissue repair and regeneration.
子宫创伤导致的宫腔粘连(IUA)是女性不孕的主要原因之一。以往研究表明,子宫内膜间充质干细胞(eMSC)通过细胞分泌对IUA具有治疗作用。在多种动物模型上进行的大多数临床前实验尤其如此,因为人源eMSC无法在动物体内长期植入。同种异体来源的组织特异性间充质干细胞是否能够植入并发挥长期治疗效果,还有待深入探究。
我们建立了大鼠IUA模型,以研究人源和大鼠源eMSC的长期植入及治疗效果。分离出人源和大鼠源eMSC,并通过细胞表面标志物的表达以及分化为成骨细胞、脂肪细胞和软骨细胞的能力进行验证。然后用绿色荧光蛋白(GFP)标记细胞,并在体外和体内移植到大鼠子宫。通过移植后不同天数GFP的表达来研究植入情况。通过检查子宫内膜厚度、腺体数量和妊娠结局来评估治疗效果。重要的是,我们对异种移植和同种异体移植后的局部细胞免疫反应进行了全面评估。
移植后三天内,人源eMSC被大鼠免疫系统清除。相比之下,大鼠源eMSC成功植入并在大鼠组织中持续存在超过十天。值得注意的是,大鼠源eMSC通过增加子宫内膜厚度和腺体数量,显著提高了妊娠率,同时还减少了大鼠IUA模型中的纤维化。此外,与异种间充质干细胞相比,对大鼠源eMSC的免疫反应通常较弱。
同种异体来源的组织特异性间充质干细胞可以整合到修复组织中,并在IUA模型中发挥长期治疗效果。本研究表明,除了短期分泌治疗因子外,组织特异性间充质干细胞可能植入并参与长期组织修复和再生。